作者
Yiming Jia,Daoxia Guo,Lulu Sun,Mengyao Shi,Kaixin Zhang,Pinni Yang,Yuhan Zang,Yu Wang,Fanghua Liu,Yonghong Zhang,Zhengbao Zhu
摘要
Abstract Aims Sleep disorders are associated with an increased risk of cardiometabolic diseases in observational studies, but the causality remains unclear. In this study, we leveraged two-sample Mendelian randomization (MR) analyses to assess the causal associations of self-reported daytime napping, daytime sleepiness, and other sleep phenotypes with cardiometabolic diseases including ischaemic stroke (IS), coronary artery disease (CAD), heart failure (HF), and Type 2 diabetes mellitus (T2DM). Methods and results We selected genetic variants as instrumental variables for self-reported daytime napping, daytime sleepiness, morning person, insomnia, short sleep duration, and long sleep duration from European-descent genome-wide association studies (GWASs). Summary statistics for cardiometabolic diseases originated from four different GWASs with a total of 2 500 086 participants. We used the inverse-variance weighted method to explore the role of self-reported sleep phenotypes on the aetiology of cardiometabolic diseases in the main analyses, followed by several sensitivity analyses for robustness validation. Genetically predicted self-reported daytime napping [T2DM: OR, 1.56 (95% confidence interval, 1.21–2.02)], insomnia [IS: OR, 1.07 (1.04–1.11)]; CAD: OR, 1.13 (1.08–1.17); HF: OR, 1.10 (1.07–1.14); T2DM: OR, 1.16 (1.11–1.22); and short sleep duration [CAD: OR, 1.37 (1.21–1.55)] were causally associated with an elevated risk of cardiometabolic diseases. Moreover, genetically determined self-reported daytime sleepiness [CAD: OR, 2.05 (1.18–3.57); HF: OR, 1.82 (1.15–2.87)] and morning person [HF: 1.06 OR, (1.01–1.11)] had potential detrimental effect on cardiometabolic risks. Conclusion Self-reported daytime napping, insomnia, and short sleep duration had causal roles in the development of cardiometabolic diseases, while self-reported daytime sleepiness and morning person was the potential risk factor for cardiometabolic diseases.